Related Experiment Video
Updated: Mar 6, 2026
Generation of 3D Tumor Spheroids for Drug Evaluation Studies
Published on: February 24, 2023
A hybrid discrete-continuous model of in vitro spheroid tumor growth and drug response
Abstract:
Anti-cancer therapy efficacy in solid tumors mainly depends on drug transportation through the vasculature system and the extracellular matrix, on diffusion gradients and clonal heterogeneity within the tumor mass, as well as on the responses of the individual tumor cells to drugs and their interactions with each other and their local microenvironment. In this work, we develop a mathematical predictive model for tumor growth and drug response based on 3D spheroids experiments that possess several in vivo features of tumors and are considered better for drug screening. The model takes into account the diffusion gradients of both oxygen and drug through the tumor volume, describes the tumor population at cell level and assumes a simple underlying cellular dose-response curve that is translated to a cell death probability. The model shows that although the endpoint tumor regression can be well approximated, the effects of the drug on cell fate necessitate a more sophisticated model to explain the temporal evolution of tumor regression and more quantitative information regarding the number and topology of dead and living cells, which is highly important for in vivo clinical relevant predictions. The model is built in a way that can be constrained by experimentally derived set of parameters and is capable of accommodating cell heterogeneity, sub-cellular regulatory mechanisms and drug-induced signaling cascades, as well as additional mechanisms of adapted resistance.
Insights
This study developed a mathematical model for anti-cancer drug efficacy in 3D tumor spheroids, accounting for diffusion and cell death. The model approximates tumor regression but requires refinement for detailed cell fate analysis in clinical predictions.
Area of Science:
- Oncology
- Mathematical Biology
- Drug Development
Background:
- Anti-cancer therapy efficacy in solid tumors is complex, influenced by drug transport, tumor heterogeneity, and cell-environment interactions.
- Three-dimensional (3D) spheroids offer a more in vivo-like model for drug screening compared to traditional methods.
Purpose of the Study:
- To develop a mathematical predictive model for tumor growth and anti-cancer drug response using 3D spheroid data.
- To incorporate diffusion gradients, cell-level population dynamics, and dose-response relationships into the model.
Main Methods:
- Utilized experimental data from 3D spheroids possessing in vivo tumor features.
- Developed a mathematical model considering oxygen and drug diffusion, cell population dynamics, and cell death probability based on a dose-response curve.
- Designed the model for parameter constraint by experimental data and accommodation of cell heterogeneity and resistance mechanisms.
Main Results:
- The model effectively approximates endpoint tumor regression.
- Analysis revealed that predicting the temporal evolution of tumor regression and detailed cell fate (dead/living cell counts and topology) requires a more sophisticated model.
- The current model provides a foundation for incorporating complex biological factors like signaling cascades and resistance.
Conclusions:
- While the model approximates tumor regression, a more advanced approach is needed for precise temporal predictions and quantitative cell fate analysis crucial for clinical relevance.
- The developed framework is adaptable for integrating experimental parameters, cell heterogeneity, and resistance mechanisms for improved predictive power in anti-cancer drug development.
